{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T19:35:34Z","timestamp":1778182534361,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s11926-009-0078-1","type":"journal-article","created":{"date-parts":[[2010,2,5]],"date-time":"2010-02-05T08:40:35Z","timestamp":1265359235000},"page":"8-18","source":"Crossref","is-referenced-by-count":28,"title":["Diagnosis and Management of Pulmonary Hypertension in Systemic Sclerosis"],"prefix":"10.1007","volume":"12","author":[{"given":"Nadera J.","family":"Sweiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Hushaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thenappan","family":"Thenappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray","family":"Sawaqed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto F.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mardi","family":"Gomberg-Maitland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliya N.","family":"Husain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Archer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,2,6]]},"reference":[{"key":"78_CR1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"UA Walker","year":"2007","unstructured":"\u2022\u2022 Walker UA, Tyndall A, Czirjak L, et al.: Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2007, 66:754\u2013763. This large European registry provides information on the predictive value of classical risk factors versus antibody profile for organ involvement in scleroderma. It concludes that anticentromere antibody patients are particularly at risk for PAH.","journal-title":"Ann Rheum Dis"},{"key":"78_CR2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.amjmed.2004.04.031","volume":"118","author":"JP Ioannidis","year":"2005","unstructured":"Ioannidis JP, Vlachoyiannopoulos PG, Haidich AB, et al.: Mortality in systemic sclerosis: an international meta-analysis of individual patient data. Am J Med 2005, 118:2\u201310.","journal-title":"Am J Med"},{"key":"78_CR3","unstructured":"Ranque B, Mouthon L: Geoepidemiology of systemic sclerosis. Autoimmun Rev 2009 Nov 10 (Epub ahead of print)."},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","volume":"66","author":"VD Steen","year":"2007","unstructured":"Steen VD, Medsger TA: Changes in causes of death in systemic sclerosis, 1972\u20132002. Ann Rheum Dis 2007, 66:940\u2013944.","journal-title":"Ann Rheum Dis"},{"key":"78_CR5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-0029-1233312","volume":"30","author":"PM Hassoun","year":"2009","unstructured":"\u2022\u2022 Hassoun PM: Pulmonary arterial hypertension complicating connective tissue diseases. Semin Respir Crit Care Med 2009, 30:429\u2013439. This article is a well-written review by an expert in pulmonary medicine who has extensive experience with the care and management of patients with SSc and various forms of pulmonary hypertension.","journal-title":"Semin Respir Crit Care Med"},{"key":"78_CR6","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1378\/chest.123.2.344","volume":"123","author":"SM Kawut","year":"2003","unstructured":"Kawut SM, Taichman DB, Archer-Chicko CL, et al.: Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003, 123:344\u2013350.","journal-title":"Chest"},{"key":"78_CR7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.jacc.2009.04.012","volume":"54","author":"G Simonneau","year":"2009","unstructured":"\u2022 Simonneau G, Robbins IM, Beghetti M, et al.: Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009, 54:S43\u2013S54. This article reviews the new WHO classification for pulmonary hypertension. The importance of distinguishing category 1 (PAH) from the more common forms of PH is evident.","journal-title":"J Am Coll Cardiol"},{"key":"78_CR8","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J, et al.: Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003, 48:2246\u20132255.","journal-title":"Arthritis Rheum"},{"key":"78_CR9","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1445-5994.2004.00646.x","volume":"35","author":"SR Cox","year":"2005","unstructured":"Cox SR, Walker JG, Coleman M, et al.: Isolated pulmonary hypertension in scleroderma. Intern Med J 2005, 35:28\u201333.","journal-title":"Intern Med J"},{"key":"78_CR10","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1183\/09031936.00042107","volume":"30","author":"T Thenappan","year":"2007","unstructured":"Thenappan T, Shah SJ, Rich S, Gomberg-Maitland M: A USA-based registry for pulmonary arterial hypertension: 1982\u20132006. Eur Respir J 2007, 30:1103\u20131110.","journal-title":"Eur Respir J"},{"key":"78_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1164\/rccm.200510-1668OC","volume":"173","author":"M Humbert","year":"2006","unstructured":"Humbert M, Sitbon O, Chaouat A, et al.: Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006, 173:1023\u20131030.","journal-title":"Am J Respir Crit Care Med"},{"key":"78_CR12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/art.10775","volume":"48","author":"V Steen","year":"2003","unstructured":"Steen V, Medsger TA Jr: Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003, 48:516\u2013522.","journal-title":"Arthritis Rheum"},{"key":"78_CR13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/ard.42.1.23","volume":"42","author":"LJ Catoggio","year":"1983","unstructured":"Catoggio LJ, Bernstein RM, Black CM, et al.: Serological markers in progressive systemic sclerosis: clinical correlations. Ann Rheum Dis 1983, 42:23\u201327.","journal-title":"Ann Rheum Dis"},{"key":"78_CR14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/01.rhu.0000152147.38706.db","volume":"11","author":"VD Steen","year":"2005","unstructured":"Steen VD: The lung in systemic sclerosis. J Clin Rheumatol 2005, 11:40\u201346.","journal-title":"J Clin Rheumatol"},{"key":"78_CR15","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s12016-008-8106-x","volume":"36","author":"FM Wigley","year":"2009","unstructured":"\u2022 Wigley FM: Vascular disease in scleroderma. Clin Rev Allergy Immunol 2009, 36:150\u2013175. This article provides a useful review of the causes and consequences of scleroderma-associated vascular disease by a leader in the field.","journal-title":"Clin Rev Allergy Immunol"},{"key":"78_CR16","first-page":"2379","volume":"29","author":"J Morse","year":"2002","unstructured":"Morse J, Barst R, Horn E, et al.: Pulmonary hypertension in scleroderma spectrum of disease: lack of bone morphogenetic protein receptor 2 mutations. J Rheumatol 2002, 29:2379\u20132381.","journal-title":"J Rheumatol"},{"key":"78_CR17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/ard.2008.088989","volume":"68","author":"V Liakouli","year":"2009","unstructured":"Liakouli V, Manetti M, Pacini A, et al.: The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis. Ann Rheum Dis 2009, 68:584\u2013590.","journal-title":"Ann Rheum Dis"},{"key":"78_CR18","first-page":"527","volume":"16","author":"A Pignone","year":"1998","unstructured":"Pignone A, Scaletti C, Matucci-Cerinic M, et al.: Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. Clin Exp Rheumatol 1998, 16:527\u2013532.","journal-title":"Clin Exp Rheumatol"},{"key":"78_CR19","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","volume":"46","author":"C Chizzolini","year":"2002","unstructured":"Chizzolini C, Raschi E, Rezzonico R, et al.: Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis. Arthritis Rheum 2002, 46:1602\u20131613.","journal-title":"Arthritis Rheum"},{"key":"78_CR20","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1002\/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H","volume":"43","author":"R Sgonc","year":"2000","unstructured":"Sgonc R, Gruschwitz MS, Boeck G, et al.: Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95. Arthritis Rheum 2000, 43:2550\u20132562.","journal-title":"Arthritis Rheum"},{"key":"78_CR21","doi-asserted-by":"crossref","first-page":"11418","DOI":"10.1073\/pnas.0610467104","volume":"104","author":"S Bonnet","year":"2007","unstructured":"Bonnet S, Rochefort G, Sutendra G, et al.: The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted. Proc Natl Acad Sci U S A 2007, 104:11418\u201311423.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"78_CR22","first-page":"1529","volume":"30","author":"JJ Choi","year":"2003","unstructured":"Choi JJ, Min DJ, Cho ML, et al.: Elevated vascular endothelial growth factor in systemic sclerosis. J Rheumatol 2003, 30:1529\u20131533.","journal-title":"J Rheumatol"},{"key":"78_CR23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1136\/thx.2004.029082","volume":"60","author":"MC Tamby","year":"2005","unstructured":"Tamby MC, Chanseaud Y, Humbert M, et al.: Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. Thorax 2005, 60:765\u2013772.","journal-title":"Thorax"},{"key":"78_CR24","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/j.jacc.2009.04.011","volume":"54","author":"DB Badesch","year":"2009","unstructured":"Badesch DB, Champion HC, Sanchez MA, et al.: Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009, 54:S55\u2013S66.","journal-title":"J Am Coll Cardiol"},{"key":"78_CR25","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1002\/art.21433","volume":"52","author":"E Hachulla","year":"2005","unstructured":"Hachulla E, Gressin V, Guillevin L, et al.: Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005, 52:3792\u20133800.","journal-title":"Arthritis Rheum"},{"key":"78_CR26","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/ard.62.11.1088","volume":"62","author":"D Mukerjee","year":"2003","unstructured":"Mukerjee D, St George D, Coleiro B, et al.: Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003, 62:1088\u20131093.","journal-title":"Ann Rheum Dis"},{"key":"78_CR27","doi-asserted-by":"crossref","unstructured":"\u2022 McLaughlin VV, Archer SL, Badesch DB, et al.: ACCF\/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation 2009, 119:2250\u20132294. (Published erratum appears in Circulation 2009, 120:e13.) This American Heart Association\/American College of Cardiology consensus document on the diagnosis and management of PAH is a useful reference article.","DOI":"10.1161\/CIRCULATIONAHA.109.192230"},{"key":"78_CR28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/art.23463","volume":"58","author":"C Meune","year":"2008","unstructured":"Meune C, Avouac J, Wahbi K, et al.: Cardiac involvement in systemic sclerosis assessed by tissue-doppler echocardiography during routine care: a controlled study of 100 consecutive patients. Arthritis Rheum 2008, 58:1803\u20131809.","journal-title":"Arthritis Rheum"},{"key":"78_CR29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/rheumatology\/36.2.239","volume":"36","author":"CP Denton","year":"1997","unstructured":"Denton CP, Cailes JB, Phillips GD, et al.: Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis. Br J Rheumatol 1997, 36:239\u2013243.","journal-title":"Br J Rheumatol"},{"key":"78_CR30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/rheumatology\/keh067","volume":"43","author":"D Mukerjee","year":"2004","unstructured":"Mukerjee D, St George D, Knight C, et al.: Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004, 43:461\u2013466.","journal-title":"Rheumatology (Oxford)"},{"key":"78_CR31","first-page":"458","volume":"35","author":"VM Hsu","year":"2008","unstructured":"Hsu VM, Moreyra AE, Wilson AC, et al.: Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization. J Rheumatol 2008, 35:458\u2013465.","journal-title":"J Rheumatol"},{"key":"78_CR32","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1002\/art.22971","volume":"56","author":"GE Tzelepis","year":"2007","unstructured":"Tzelepis GE, Kelekis NL, Plastiras SC, et al.: Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007, 56:3827\u20133836.","journal-title":"Arthritis Rheum"},{"key":"78_CR33","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/art.1780350709","volume":"35","author":"VD Steen","year":"1992","unstructured":"Steen VD, Graham G, Conte C, et al.: Isolated diffusing capacity reduction in systemic sclerosis. Arthritis Rheum 1992, 35:765\u2013770.","journal-title":"Arthritis Rheum"},{"key":"78_CR34","unstructured":"Chandra S, Shah SJ, Thenappan T, et al.: Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension. J Heart Lung Transplant 2009 Sep 25 (Epub ahead of print)."},{"key":"78_CR35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/art.1780350114","volume":"35","author":"Y Okano","year":"1992","unstructured":"Okano Y, Steen VD, Medsger TA Jr: Autoantibody to U3 nucleolar ribonucleoprotein (fibrillarin) in patients with systemic sclerosis. Arthritis Rheum 1992, 35:95\u2013100.","journal-title":"Arthritis Rheum"},{"key":"78_CR36","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1136\/ard.2008.098087","volume":"68","author":"Y Allanore","year":"2009","unstructured":"Allanore Y, Wahbi K, Borderie D, et al.: N-terminal brain natriuretic peptide in systemic sclerosis: a new cornerstone of cardiovascular assessment? Ann Rheum Dis 2009 68:1885\u20131889.","journal-title":"Ann Rheum Dis"},{"key":"78_CR37","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10067-008-0837-9","volume":"27","author":"M Ciurzynski","year":"2008","unstructured":"Ciurzynski M, Bienias P, Lichodziejewska B, et al.: Non-invasive diagnostic and functional evaluation of cardiac involvement in patients with systemic sclerosis. Clin Rheumatol 2008, 27:991\u2013997.","journal-title":"Clin Rheumatol"},{"key":"78_CR38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1183\/09031936.01.17406470","volume":"17","author":"G Paciocco","year":"2001","unstructured":"Paciocco G, Martinez FJ, Bossone E, et al.: Oxygen desaturation on the six-minute walk test and mortality in untreated primary pulmonary hypertension. Eur Respir J 2001, 17:647\u2013652.","journal-title":"Eur Respir J"},{"key":"78_CR39","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1161\/CIRCHEARTFAILURE.108.807826","volume":"2","author":"SJ Shah","year":"2009","unstructured":"Shah SJ, Thenappan T, Rich S, et al.: Value of exercise treadmill testing in the risk stratification of patients with pulmonary hypertension. Circ Heart Fail 2009, 2:278\u2013286.","journal-title":"Circ Heart Fail"},{"key":"78_CR40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.08-2784","volume":"136","author":"SD Halpern","year":"2009","unstructured":"Halpern SD, Taichman DB: Misclassification of pulmonary hypertension due to reliance on pulmonary capillary wedge pressure rather than left ventricular end-diastolic pressure. Chest 2009, 136:37\u201343.","journal-title":"Chest"},{"key":"78_CR41","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.22069","volume":"54","author":"MR Fisher","year":"2006","unstructured":"Fisher MR, Mathai SC, Champion HC, et al.: Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 2006, 54:3043\u20133050.","journal-title":"Arthritis Rheum"},{"key":"78_CR42","doi-asserted-by":"crossref","first-page":"78S","DOI":"10.1378\/chest.126.1_suppl.78S","volume":"126","author":"VV McLaughlin","year":"2004","unstructured":"McLaughlin VV, Presberg KW, Doyle RL, et al.: Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004, 126:78\u00a0S\u201392\u00a0S.","journal-title":"Chest"},{"key":"78_CR43","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJM199602013340504","volume":"334","author":"RJ Barst","year":"1996","unstructured":"Barst RJ, Rubin LJ, Long WA, et al.: A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. The Primary Pulmonary Hypertension Study Group. N Engl J Med 1996, 334:296\u2013302.","journal-title":"N Engl J Med"},{"key":"78_CR44","doi-asserted-by":"crossref","first-page":"425","DOI":"10.7326\/0003-4819-132-6-200003210-00002","volume":"132","author":"DB Badesch","year":"2000","unstructured":"Badesch DB, Tapson VF, McGoon MD, et al.: Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med 2000, 132:425\u2013434.","journal-title":"Ann Intern Med"},{"key":"78_CR45","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Badesch DB, McGoon MD, Barst RJ, et al.: Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol. J Rheumatol 2009, 36:2244\u20132249.","DOI":"10.3899\/jrheum.081277"},{"key":"78_CR46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1378\/chest.126.2.420","volume":"126","author":"RJ Oudiz","year":"2004","unstructured":"Oudiz RJ, Schilz RJ, Barst RJ, et al.: Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest 2004, 126:420\u2013427.","journal-title":"Chest"},{"key":"78_CR47","doi-asserted-by":"crossref","unstructured":"Rubin LJ, Badesch DB, Barst RJ, et al.: Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002, 346:896\u2013903. (Published erratum appears in N Engl J Med 2002, 346:1258.)","DOI":"10.1056\/NEJMoa012212"},{"key":"78_CR48","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/ard.2007.079921","volume":"67","author":"CP Denton","year":"2008","unstructured":"Denton CP, Pope JE, Peter HH, et al.: Long-term effects of bosentan on quality of life, survival, safety and tolerability in pulmonary arterial hypertension related to connective tissue diseases. Ann Rheum Dis 2008, 67:1222\u20131228.","journal-title":"Ann Rheum Dis"},{"key":"78_CR49","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.healun.2004.12.113","volume":"24","author":"RE Girgis","year":"2005","unstructured":"Girgis RE, Mathai SC, Krishnan JA, et al.: Long-term outcome of bosentan treatment in idiopathic pulmonary arterial hypertension and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases. J Heart Lung Transplant 2005, 24:1626\u20131631.","journal-title":"J Heart Lung Transplant"},{"key":"78_CR50","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1056\/NEJMct0904473","volume":"361","author":"SL Archer","year":"2009","unstructured":"Archer SL, Michelakis ED: Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. N Engl J Med 2009, 361:1864\u20131871.","journal-title":"N Engl J Med"},{"key":"78_CR51","first-page":"2417","volume":"34","author":"DB Badesch","year":"2007","unstructured":"Badesch DB, Hill NS, Burgess G, et al.: Sildenafil for pulmonary arterial hypertension associated with connective tissue disease. J Rheumatol 2007, 34:2417\u20132422.","journal-title":"J Rheumatol"},{"key":"78_CR52","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/CIRCULATIONAHA.108.839274","volume":"119","author":"N Galie","year":"2009","unstructured":"Galie N, Brundage BH, Ghofrani HA, et al.: Tadalafil therapy for pulmonary arterial hypertension. Circulation 2009, 119:2894\u20132903.","journal-title":"Circulation"},{"key":"78_CR53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/ard.2007.077149","volume":"67","author":"J Avouac","year":"2008","unstructured":"Avouac J, Wipff J, Kahan A, Allanore Y: Effects of oral treatments on exercise capacity in systemic sclerosis related pulmonary arterial hypertension: a meta-analysis of randomised controlled trials. Ann Rheum Dis 2008, 67:808\u2013814.","journal-title":"Ann Rheum Dis"},{"key":"78_CR54","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1002\/art.22264","volume":"54","author":"L Schachna","year":"2006","unstructured":"Schachna L, Medsger TA Jr, Dauber JH, et al.: Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension. Arthritis Rheum 2006, 54:3954\u20133961.","journal-title":"Arthritis Rheum"},{"key":"78_CR55","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1136\/ard.2008.096677","volume":"68","author":"O Kowal-Bielecka","year":"2009","unstructured":"Kowal-Bielecka O, Landewe R, Avouac J, et al.: EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009, 68:620\u2013628.","journal-title":"Ann Rheum Dis"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0078-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-009-0078-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-009-0078-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T09:26:13Z","timestamp":1634894773000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-009-0078-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s11926-009-0078-1","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}